AMGN

Amgen Inc.

Halal Rating :
Uncomfortable
See Details
Last Price $311.54 Last updated:
Market Cap $148.24b
7D Change 15.39%
1 Year Change 34.35%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date Nov. 2, 2023

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $7.63b $13.12b - $821.0m 0.00% 6.26%
Sept. 30, 2023 $6.33b $7.8b - $759.0m 0.00% 9.73%
June 30, 2023 $6.35b $7.74b - $752.0m 0.00% 9.72%

Company Impact

Help us evaluate Amgen Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates